Abstract:Matrix metalloproteinases are involved in a complex multifactorial process of atherosclerotic plaque formation and play a leading role in the degradation of the extracellular matrix components and increase the migratory activity of cellular elements of the vascular wall. Despite a number of scientific studies, it is necessary to identify clear biochemical markers for the development of atherosclerotic lesions. The purpose of the study was to investigate the relationship between the activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in myocardial homogenate with changes of the cells composition in the coronary arteries wall in experimental atherosclerosis. Materials and methods. The studies were performed on 76 nonlinear rats, which were divided into 3 groups: group Ia was the control (n=20) – animals, injected intracutaneously with 0.1 ml of 0.9 % sodium chloride solution; Ib – comparison group (n=20) – animals injected with incomplete Freund’s adjuvant at the dose of 0.1 ml intracutaneously and II – experimental group (n=36), which were immunized with native human low-density lipoprotein at a single dose of 200 μg, diluted in 0.1 ml of incomplete Freund’s adjuvant, regardless of the weight. The experiment lasted for 20 weeks. Material sampling was performed, starting from the 4th week after the drug administration. From the coronary arteries and the adjacent myocardium, microslides were made according to the generally accepted technique, which were stained with hematoxylin and eosin, according to the methods of Van Gizon, Mallory and Sudan III. The activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 was determined by enzyme-zimografic method. Results and discussion. The growth of matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in atherosclerotic lesions showed stages of degradation of extracellular matrix components: the dynamics of matrix metalloproteinase-2 activity during the experiment increased from 109.1±1.23 % at the 12th week to 127.32±0.99 % at the 20th week. The increased activity of matrix metalloproteinase-2 was associated with an increase in the number of leukocytes and macrophages, including foam cells. The activity of matrix metalloproteinase-9 reached the highest values of 98.24±0.82% at the 8th period from the onset of changes to the final level of 86.26±0.54% at the maximum terms of the experiment. Conclusion. The growing activity of matrix metalloproteinase-9 indicated the development of early atherosclerotic lesions, while the high level of activity of matrix metalloproteinase-2 indicated significant structural changes in the wall of the coronary arteries

Comparative study of tissue expressions of matrix metalloproteinase-9 in human abdominal aortic aneurysms and arterial occlusive diseases

Expression of matrix metalloproteinase-9 in thoracic aortic dissection and aneurysm

The Expression of Matrix Metalloproteinase-9 and the Pathological Changes of Vascular Smooth Muscle Cell in Patients with Acute Ascending Aortic Dissection

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

MMP-9 and Ultrastructural Study of Intracranial Aneurysms

The Study of Ultrastructural and Regulation Mechain of MMP-9's Overexpression in the Patiens with Intracranial Aneurysms

Relationship between the Activity of Matrix Metalloproteinase-2 and -9 in Myocardial Homogenate with Changes of the Cells Composition in the Coronary Arteries Wall in the Experiment

Osteoprotegerin expression in abdominal aortic aneurysm tissue and its impact

Expression of matrix metalloproteinase and Ⅳ type collagen in thoracic aortic aneurysms with Marfan's syndrome

TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas

Abstract 97: Spatiotemporal Expression Of Matrix Metalloproteinases (mmps) Is Regulated By Ca2+-signal Transducer S100a4 In The Thoracic Aortic Aneurysm Pathogenesis

Expression of matrix metalloproteinases-9 and vascular endothelial growth factor in intracranial aneurysms

Overexpression of Interleukin-1Β and Interferon-Γ in Type I Thoracic Aortic Dissections and Ascending Thoracic Aortic Aneurysms: Possible Correlation with Matrix Metalloproteinase-9 Expression and Apoptosis of Aortic Media Cells

Effect of Matrix Metalloproteinase and Its Inhibitor in the Formation of Abdominal Aortic Aneurysms

Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection

The Role of Matrix Metalloproteinases in Thoracic Aortic Disease: Are They Indicators for the Pathogenesis of Dissections?

Clinical Significance of Serum MMP-9 Level in Acute Aortic Dissection Presenting with Abdominal Pain

Temporal and Quantitative Analysis of Expression of Metalloproteinases (mmps) and Their Endogenous Inhibitors in Atherosclerotic Lesions.

Extracellular matrix metalloproteinase inducer (EMMPRIN) is present in smooth muscle cells of human aneurysmal aorta and is induced by angiotensin II in vitro.

The Expression of MMP-7 in Serum and Aneurysm Tissues of Patients with Abdominal Aortic Aneurysm Associated with Hypertension and the Clinical Efficacy of Endovascular Exclusion.

Significance of the Detection of Serum Levels of Matrix Metalloproteinases -1,-2,-3 and -9 in Thoracic Aortic Diseases and Acute Myocardial Ischemia